The Journal of Maternal-Fetal & Neonatal Medicine · 2017 · 26 citations · 32 references
Life SciencesNeurosciencePharmacologyBehavioral NeuroscienceDevelopmental NeurosciencePsychopharmacologyDevelopmental Behavioral NeuroscienceDevelopmental NeuropharmacologyPerinatal PharmacologyPrenatal DevelopmentSerotonergic PharmacologySerotonergic SignalingPerinatal Drug ExposurePrenatal Drug ExposurePrenatal NeuropharmacologySelective Serotonin Reuptake Inhibitor TreatmentSelective Serotonin Reuptake Inhibitor UseSerotonergic MechanismsSerotonin Receptor Gene ExpressionSerotonin Receptor Subtypes
PURPOSE: Associations have been made between maternal selective serotonin reuptake inhibitor (SSRI) use during pregnancy and altered behavior in offspring, including an increased risk of autism. Given the important role serotonin plays in behavior, we hypothesized SSRI exposure in the perinatal period would alter central serotonin receptor expression and program adult behaviors in mice. METHODS: Female mice were injected with sertraline or saline throughout pregnancy. Offspring continued to receive injections on postnatal days 1-14, a time period in mice similar to the third trimester in human pregnancy. Adult offspring underwent behavioral testing, and serotonin receptor mRNA levels were quantified. RESULTS: Compared to controls, SSRI exposed mice did not have a reduction in social interactions, spatial learning, or exploratory behavior. As adults, sertraline exposed mice had significantly increased mRNA levels of multiple 5-HT receptors, serotonin transporter (5-HTT), and tryptophan hydroxylase isoform 2 in the cerebral cortex. CONCLUSION: Although no behavioral phenotype was observed, SSRI exposure in the perinatal period permanently alters cerebral receptor mRNA levels. We speculate these shifts in mRNA expression provide important compensation during SSRI exposure. Further pre-clinical and clinical investigation into additional serotonin-regulated phenotypes is necessary to further assess the long-term implications of perinatal SSRI exposure.
32
Neurodevelopment of Children Exposed in Utero to Antidepressant Drugs
Irena Nulman, Joanne Rovet, Donna E. Stewart et al. · New England Journal of Medicine · 1997 · 578 citations · Full text
Medicine, Pediatrics, Psychiatry +17
Tim F. Oberlander, William Warburton, Shaila Misri et al. · Archives of General Psychiatry · 2006 · 548 citations
Medicine, Obstetrics, Psychiatry +16
Increasing use of antidepressants in pregnancy
William O. Cooper, Mary E. Willy, Stephen J. Pont et al. · American Journal of Obstetrics and Gynecology · 2007 · 456 citations